Exagen Inc.XGNNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank3
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P3
Near historical low
vs 3Y Ago
-11.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-214.54%
Q3 2025186.26%
Q2 202571.31%
Q1 2025-5069.59%
Q4 2024109.34%
Q3 20249.33%
Q2 202471.93%
Q1 2024-210.71%
Q4 2023383.26%
Q3 202372.23%
Q2 2023-3.28%
Q1 2023-65.23%
Q4 202218.79%
Q3 202242.28%
Q2 2022-35.60%
Q1 2022-35.86%
Q4 2021-20.83%
Q3 2021-13.96%
Q2 2021-15.29%
Q1 2021-14.73%
Q4 2020-66.77%
Q3 202052.31%
Q2 2020-45.02%
Q1 202014.37%
Q4 2019-136.99%
Q3 201923.49%
Q2 20195.75%
Q1 2019-19.23%
Q4 20186.91%
Q3 2018-4.51%
Q2 201842.73%
Q1 20180.00%
Q4 2015-12.76%
Q3 20152.96%
Q2 2015-16.31%
Q1 2015-11.99%
Q4 20143.16%
Q3 201417.91%
Q2 20143.55%
Q1 2014-35.71%